Quantchabot has detected a promising Short Risk Reversal trade opportunity for REGENERON PHARMACEUTICALS (REGN) for the 19-Dec-2025 expiration period. You can analyze the opportunity in depth over at the Quantcha Options Search Engine.
REGN was recently trading at $834.40 and has an implied volatility of 28.81% for this period. Based on an analysis of the options available for REGN expiring on 19-Dec-2025, there is a 22.54% likelihood that the underlying will close within the analyzed range of $612.72-$834.40 at expiration. In this scenario, the average linear return for the trade would be 131.74%.
Trending on StockTwits: StockTwits® is a financial communications platform for the financial and investing community. On their site, REGENERON PHARMACEUTICALS was recently trending, indicating that breaking news and/or market activity has significantly impacted sentiment toward the stock. This movement can be interpretted as a sign of more near-term price movement for the underlying.
Trade approach: The recent sentiment change in REGN on StockTwits appears to be significantly negative, indicating that the stock is likely to follow in that direction for investors trading on sentiment. As a result, a bearish strategy could prove effective if the sentiment ultimately turns out to drive trading.
Upside potential: Using this bearish strategy, the trade would be profitable if REGENERON PHARMACEUTICALS closed at or below $1,045.60 on 19-Dec-2025. Based on our analysis, there is a 58.71% likelihood of this return.
Downside risk: As with any options trade, there is a substantial downside risk where you may lose most or all of your investment.
To analyze this trade in depth, please visit the Quantcha Options Search Engine.